Ontario to fund use of Velcade for patients with fatal form of blood cancer

TORONTO - A company which manufactures a treatment for multiple myeloma says the medication Velcade will now be covered by Ontario's drug plan. Ortho Biotch says Velcade is a first-line therapy for patients who are not candidates for stem cell transplants....More